# INvestigating TELmisartin Study

> **NCT04715763** · PHASE2 · TERMINATED · sponsor: **University of Hawaii** · enrollment: 24 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Telmisartan Oral Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04715763
- **Lead sponsor:** University of Hawaii
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-04-26
- **Final completion:** 2022-04-26
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Poor recruitment due to decrease in COVID-19 rates locally
- **Last updated:** 2022-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04715763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04715763, "INvestigating TELmisartin Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04715763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*